How are you feeling today? Keep up to date on news and stories related to healthcare here!
Double-masking is a sensible and easy way to lower your risk when you have to spend more time around others — in a taxi, on a train or plane, or at an inauguration. — NYT: Top Stories
The scramble to vaccinate New Yorkers has not yet had a significant impact on rising rates of positive tests in many city neighborhoods. — NYT: Top Stories
Expands Focus on Sulfur Nutrition for Wide Variety of Crops Including Soybeans Robust Operational Performance Supports Improved Granular Conversion Acquires Certain Assets of Commonwealth Industrial Services (CIS), Adding Packaging, Warehousing and Logistics Capabilities PARSIPPANY, N.J. & HOPEWELL, Va. — (BUSINESS WIRE) —
As the Biden administration proposes additional pandemic relief, nonprofit workers see a country facing a growing crisis. — NYT: Top Stories
TRENTON, N.J. — Looking forward to the next phase of the COVID-19 pandemic response, Mercer County has opened a COVID-19 vaccination facility at CURE Arena in Trenton this week. The vaccination clinic will be a partnership of the CURE Arena with Capital
In CheckMate -9ER, OPDIVO in combination with CABOMETYX doubled median progression-free survival and objective response rate and showed superior overall survival vs. sunitinib1 Approved across all International Metastatic Renal Cell Carcinoma Database Consortium risk categories1,2 Approval expands Company’s presence in first-line advanced
FILE – Cutout photos of people, including first responders and healthcare workers, sit in seats in Gillette Stadium before an NFL football game between the New England Patriots and the Buffalo Bills in Foxborough, Mass., in this Monday, Dec. 28, 2020, file
New daily cases are starting to slow in what some health experts see as a turning point. But they warn of a bumpy vaccination rollout amid the emergence of more contagious variants. — NYT: Top Stories
U.S. Food and Drug Administration assigned a target action date of May 25, 2021 PRINCETON, N.J. — (BUSINESS WIRE) — $BMY #BMS—Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License